FMO5 and endothelial dysfunction: To elucidate the source of increases in endothelial oxidative stress and the resulting endothelial dysfunction, we administered NOS inhibitor L-NAME, eNOS co-factor BH4, NADPH oxidases inhibitor apocynin, or peg-SOD in conjunction with TNFα treatment.